- Home
- BEAM vs PTY Comparison
BEAM vs PTY Comparison
Compare BEAM & PTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEAM
- PTY
- Stock Information
- Founded
- BEAM 2017
- PTY 2002
- Country
- BEAM United States
- PTY United States
- Employees
- BEAM N/A
- PTY N/A
- Industry
- BEAM Biotechnology: Biological Products (No Diagnostic Substances)
- PTY Investment Managers
- Sector
- BEAM Health Care
- PTY Finance
- Exchange
- BEAM Nasdaq
- PTY Nasdaq
- Market Cap
- BEAM 1.9B
- PTY 2.2B
- IPO Year
- BEAM 2020
- PTY N/A
- Fundamental
- Price
- BEAM $24.41
- PTY $14.49
- Analyst Decision
- BEAM Buy
- PTY
- Analyst Count
- BEAM 10
- PTY 0
- Target Price
- BEAM $47.67
- PTY N/A
- AVG Volume (30 Days)
- BEAM 1.2M
- PTY 550.4K
- Earning Date
- BEAM 02-25-2025
- PTY 01-01-0001
- Dividend Yield
- BEAM N/A
- PTY 9.65%
- EPS Growth
- BEAM N/A
- PTY N/A
- EPS
- BEAM N/A
- PTY N/A
- Revenue
- BEAM $349,643,000.00
- PTY N/A
- Revenue This Year
- BEAM N/A
- PTY N/A
- Revenue Next Year
- BEAM $14.08
- PTY N/A
- P/E Ratio
- BEAM N/A
- PTY N/A
- Revenue Growth
- BEAM 328.73
- PTY N/A
- 52 Week Low
- BEAM $20.84
- PTY $11.92
- 52 Week High
- BEAM $49.50
- PTY $14.88
- Technical
- Relative Strength Index (RSI)
- BEAM 42.12
- PTY 56.06
- Support Level
- BEAM $22.50
- PTY $14.35
- Resistance Level
- BEAM $28.39
- PTY $14.45
- Average True Range (ATR)
- BEAM 1.56
- PTY 0.09
- MACD
- BEAM -0.33
- PTY 0.02
- Stochastic Oscillator
- BEAM 27.67
- PTY 97.27
About BEAM Beam Therapeutics Inc.
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.
About PTY Pimco Corporate & Income Opportunity Fund
PIMCO Corporate & Income Opportunity Fds operates as a closed-end management investment company. It seeks to maximize total return through a combination of current income and capital appreciation. The fund invests a majority of the total assets in a combination of corporate debt obligations of varying maturities, other corporate income-producing securities, and income-producing securities of non-corporate issuers, such as U.S. Government securities, municipal securities, and mortgage-backed and other asset-backed securities issued on a public or private basis.